BlackBarn Capital Partners LP In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), BlackBarn Capital Partners LP reported 18 stock positions worth $230.1 million . Its top holding was Roivant Sciences (ROIV) at 20.1% of the portfolio, followed by Molina Healthcare (MOH, 9.0% ) and Amneal Pharmaceuticals (AMRX, 8.7% ). Compared with Q2 2024, it opened 3 new positions, sold out of 2, added to 10 and reduced 1. The biggest buy was Roivant Sciences (ROIV, shares +29% ) and the biggest sale an exit from RH (RH).
Location NEW YORK, NY
CIK 0002010204
Portfolio Value $230.1M (Q3 2024) Holdings 18 stocks · $230.1M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2024 ROIV Roivant Sciences Ltd. 20.06% 4,000,000 $46.2M Add +29.0% MOH Molina Healthcare Inc. 8.98% 60,000 $20.7M Add +14.3% AMRX Amneal Pharmaceuticals Inc. 8.72% 2,411,612 $20.1M Add +20.6% DHC Diversified Healthcare Trust 8.03% 4,408,497 $18.5M Add +10.2% T AT&T Inc. 7.17% 750,000 $16.5M Add +25.0% UNH Unitedhealth Group Inc. 6.53% 25,700 $15.0M Reduce -19.7% BRBS Blue Ridge Bankshares Inc. 5.72% 4,702,747 $13.2M No change CIVI Civitas Resources Inc. 5.51% 250,000 $12.7M Add +78.6% ELV Elevance Health Inc. 5.08% 22,500 $11.7M Add +25.0% CHRD Chord Energy Corp. 4.53% 80,000 $10.4M Add +25.0% TEVA Teva Pharmaceutical-SP ADR 3.97% 506,971 $9.1M Add +1.4% ABUS Arbutus Biopharma Corp. 3.47% 2,070,900 $8.0M No change BVFL BV Financial Inc. filed as BV FINL INC 3.20% 480,000 $7.4M No change PRVA Privia Health Group Inc. 3.17% 400,000 $7.3M No change LW Lamb Weston Holdings Inc. 2.46% 87,500 $5.7M New TCBX Third Coast Bancshares Inc. 2.27% 194,893 $5.2M Add +29.9% MODVQ Modivcare Inc. 0.62% 100,577 $1.4M New BCBP BCB Bancorp Inc. 0.51% 94,288 $1.2M New
Options reported separately and not counted above: SPY puts ($286.9M), QQQ puts ($244.0M).
Portfolio Sells Q2 2024 → Q3 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▲ RH RH Sold out 0.00% −5.50 KNF Knife River Corp. Sold out 0.00% −4.88 UNH Unitedhealth Group Inc. Reduce -19.7% 6.53% −1.87
Portfolio Buys Q2 2024 → Q3 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▼ ROIV Roivant Sciences Ltd. Add +29.0% 20.06% +3.17 LW Lamb Weston Holdings Inc. New 2.46% +2.46 AMRX Amneal Pharmaceuticals Inc. Add +20.6% 8.72% +2.17 DHC Diversified Healthcare Trust Add +10.2% 8.03% +1.74 T AT&T Inc. Add +25.0% 7.17% +1.26 MOH Molina Healthcare Inc. Add +14.3% 8.98% +0.94 MODVQ Modivcare Inc. New 0.62% +0.62 TCBX Third Coast Bancshares Inc. Add +29.9% 2.27% +0.62 CIVI Civitas Resources Inc. Add +78.6% 5.51% +0.53 BCBP BCB Bancorp Inc. New 0.51% +0.51 ELV Elevance Health Inc. Add +25.0% 5.08% +0.06 TEVA Teva Pharmaceutical-SP ADR Add +1.4% 3.97% −0.22 CHRD Chord Energy Corp. Add +25.0% 4.53% −1.00
Options Activity Q2 2024 → Q3 2024 Security Type Change vs Q2 2024 Underlying Shares Value ▼ SPY SS SPDR S&P 500 ETF Trust-US put New 500,000 $286.9M QQQ Invesco QQQ Trust Series 1 put Reduce -60.0% 500,000 $244.0M NVDA Nvidia Corp. put Sold out 1,700,000 $210.0Mbefore exit COIN Coinbase Global Inc. Class A put Sold out 500,000 $111.1Mbefore exit ODD Oddity Tech Ltd. Class A put Sold out 282,700 $11.1Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 17 $402.2M ROIV, PRVA, DHC, NEE, NIQ Q1 2026 14 $332.4M ROIV, VECO, PRVA, DHC, NEE Q4 2025 11 $278.9M ROIV, DHC, PRVA, NIQ, NEE Q3 2025 15 $306.4M ROIV, PRVA, DHC, NXT, AMRX Q2 2025 20 $301.8M ROIV, AMRX, ACLS, DHC, MOH Q1 2025 18 $292.8M ROIV, UNH, MOH, AMRX, ACLS Q4 2024 15 $254.1M ROIV, UNH, MOH, TEVA, AMRX Q3 2024 18 $230.1M ROIV, MOH, AMRX, DHC, T Q2 2024 17 $194.0M ROIV, UNH, MOH, AMRX, BRBS Q1 2024 21 $173.0M ROIV, MOH, UNH, CHRD, CF